LACOSAMIDE
Body System:
Manner of administration:Oral
Restriction (Streamlined authority code: 17515)
Indication: Idiopathic generalised epilepsy with primary generalised tonic-clonic seizures
Treatment phase: Dose titration at the start of therapy, during therapy or to gradually cease treatment
Body System:
Manner of administration:Oral
Restriction (Streamlined authority code: 17541)
Indication: Intractable focal onset seizures
Treatment phase: Initial treatment
